Valuation (84%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.30 | 4.81 |
| PEG Ratio (TTM) | 0.06 | -1.08 |
| P/S Ratio (TTM) | 10.16 | 51.93 |
| P/B Ratio (TTM) | 0.93 | 0.94 |
| P/FCF Ratio (TTM) | 14.10 | 18.49 |
| Price to 5YR AVG Earnings Ratio | 21.49 | 26.70 |
| Price to 5YR AVG FCF Ratio | 1.67 | 29.10 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.27% | 1.17% |
| ROE (TTM) | 14.82% | 5.34% |
| Net Profit Margin (TTM) | 163.53% | 28.56% |
| ROIC 5YR AVG | 7.24% | 7.78% |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 85.04% | 2,940.14% | 1,826.14% |
| Revenue | 116.37% | 4,188.62% | 2,581.26% |
| Net Income | 60.87% | 1,494.04% | 958.71% |
| Cash Flow | -8.52% | 712.45% | 425.48% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.06 | 1.63 |
| Quick Ratio (TTM) | 0.06 | 1.59 |
| D/E Ratio (TTM) | 0.43 | 0.72 |
| Interest Coverage (TTM) | 4.72 | 19.98 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.01 | 7.47 |
| LTL to 5YR AVG FCF | N/A | 9.40 |
| Shares Outstanding Growth 5YR AVG | -9.74% | -0.98% |